Carbohydrate Loading on Insulin Resistance in Open Heart Surgery
The Effect of Preoperative Oral Carbohydrate Solution Administration of Insulin Resistance in Patients Undergoing Elective Open-Heart Surgery
1 other identifier
interventional
40
1 country
1
Brief Summary
This study is a single-blind randomized clinical trial involving 40 adult patients undergoing elective open-heart surgery. The sample was allocated into two groups: 20 subjects in the oral carbohydrate fluid group and 20 subjects in the water group consumed 2 hours before surgery. Insulin resistance was measured by blood glucose levels, HOMA-IR index, and insulin tolerance tests. Postoperative outcomes were assessed by ICU stay duration, ventilator use, and hospital stay duration. Patient comfort factors were measured by hunger, thirst, nausea, and comfort levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2024
CompletedFirst Submitted
Initial submission to the registry
July 15, 2024
CompletedFirst Posted
Study publicly available on registry
March 30, 2025
CompletedApril 2, 2025
March 1, 2025
9 months
July 15, 2024
March 28, 2025
Conditions
Outcome Measures
Primary Outcomes (10)
Insulin resistance difference between two groups
Insulin resistance seen in the level of blood glucose (mg/dL)
Within 30 minutes before and 30 minutes after operation
Insulin resistance difference between two groups
Insulin resistance seen in the level HOMA-IR (unitless)
Within 30 minutes before and 30 minutes after operation
Insulin resistance difference between two groups
Insulin resistance seen in the level insulin sensitivity test (%/minute)
Within 30 minutes before and 30 minutes after operation
Operation outcome difference between two groups
Operation outcome in form of length of stay in the ICU (days)
From completion of operation to ICU discharge or death, usually under 28 days
Operation outcome difference between two groups
Operation outcome in form of length of stay in the hospital (days)
From completion of operation to hospital discharge or death, usually under 28 days
Operation outcome difference between two groups
Operation outcome consists of duration of ventilator use (days)
From completion of operation to cessation of ventilator use or death, usually under 28 days
Subjective well being difference between two groups
Subjective well being in form of hunger (Yes or No)
Preoperatively in the preparation room, usually around 1 hour before operation
Subjective well being difference between two groups
Subjective well being in form of thrist (Yes or No)
Preoperatively in the preparation room, usually around 1 hour before operation
Subjective well being difference between two groups
Subjective well being in form of nausea (Yes or No)
Preoperatively in the preparation room, usually around 1 hour before operation
Subjective well being difference between two groups
Subjective well being in form of comfort (Yes or No)
Preoperatively in the preparation room, usually around 1 hour before operation
Study Arms (2)
Mineral water
NO INTERVENTIONPatient is given mineral water 2 hours before operation
Glucose Drink
EXPERIMENTALPatient is given glucose water 2 hours before operation
Interventions
Intervention group will receive maltodextrin glucose drinks 2 hours prior to the operation
Eligibility Criteria
You may qualify if:
- Subjects age 18-65 years old undergoing elective open heart surgery
- Subjects giving informed consent
You may not qualify if:
- Subjects with diabetes mellitus
- Subjects with gastroesophageal reflux
- Subjects with digestive malignancy
- Subjects with dementia
- Subjects with mental health
- Subjects with ASA 4 or more
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rumah Sakit Cipto Mangunkusumo
Jakarta Pusat, DKI Jakarta, 1043, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Investigator is blinding to the intervention given to the subjects
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 15, 2024
First Posted
March 30, 2025
Study Start
January 1, 2023
Primary Completion
October 10, 2023
Study Completion
January 5, 2024
Last Updated
April 2, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share